Cytomegalovirus Donor and Recipient Serostatus and 5‐Year Mortality After Heart Transplantation: Evidence of Racial Differences
- 27 October 2026
- journal article
- Published by Wiley in Transplant Infectious Disease
Abstract
Background: Cytomegalovirus (CMV) donor/recipient (D/R) serostatus is an established determinant of post‐transplant outcomes in heart transplantation (HT); however, the extent to which demographic and socioeconomic (SE) factors modify CMV‐related mortality risk remains unclear. Methods: Using the scientific registry of transplant recipients, we evaluated whether demographic and SE factors alter the association between CMV D/R serostatus and 5‐year all‐cause mortality among first‐time, adult HT recipients (2010–2024). Multivariable competing risk models estimated sub‐distribution hazard ratios (sHRs) for CMV D/R serostatus interacted with age, sex, race/ethnicity, and Distressed Community Index (DCI) categories. Results: CMV D+/R− and CMV D+/R+ serostatus were associated with increased 5‐year mortality. Effect modification varied by subgroup. Age, sex, and DCI did not significantly modify CMV‐associated mortality, suggesting consistent relative risk across these strata. In contrast, race/ethnicity significantly modified the association with attenuated mortality among Black HT recipients compared with White HT recipients (reference). The sHR for mortality comparing Black CMV D−/R− and CMV D+/R+ HT recipients was 0.69 lower (95% CI: 0.57–0.84; p ‐value < 0.001) than the corresponding estimate in White HT recipients. Similarly, the sHR comparing Black CMV D−/R− and CMV D−/R+ HT recipients was 0.78 lower (95% CI: 0.63–0.97; p ‐value = 0.024) than the White HT recipients. No significant differences were observed between White and Hispanic/Other racial/ethnic groups. Conclusions: CMV‐related mortality risk was evident among White recipients, however, the effect of CMV on post‐transplant outcomes is attenuated in Black recipients. These findings highlight heterogeneity in CMV‐associated risk and support more individualized CMV prevention and monitoring strategies incorporating demographic context.Keywords
This publication has 19 references indexed in Scilit:
- Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ TransplantJAMA Network Open, 2024
- Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donorsThe Journal of Heart and Lung Transplantation, 2023
- An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic TransplantationTransplantation and Cellular Therapy, 2021
- Donor Graft Cytomegalovirus Serostatus and the Risk of Arterial and Venous Thrombotic Events in Seronegative Recipients After Non-Thoracic Solid Organ TransplantationClinical Infectious Diseases, 2020
- Age and immunity: What is “immunosenescence”?Experimental Gerontology, 2018
- Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and ManagementJournal of Clinical and Experimental Hepatology, 2017
- Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an updateExpert Opinion on Pharmacotherapy, 2016
- Review of cytomegalovirus seroprevalence and demographic characteristics associated with infectionReviews in Medical Virology, 2010
- Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004Clinical Infectious Diseases, 2010
- An Assessment of Donor‐to‐Recipient Transmission Patterns of Human Cytomegalovirus by Analysis of Viral Genomic VariantsThe Journal of Infectious Diseases, 2009